Earlier this year our dear friend and colleague Professor Tony Dodi died suddenly. He was a Scientist of immense integrity and worked with many of the authors who have contributed to the current series of articles focussing on Cancer Biomarkers. His laboratory at Nottingham Trent University (NTU) authored the article entitled “NK Cells, monocytes and Non T-cell biomarkers as prognostic indicators in cancer immunotherapy” in issue 1 and he contributed enormously to the progress and wellbeing of the ENACT Research programme funded by the EU under FP6. During his career, Tony worked with Robert Lachler and Richard Bachelor at The Royal Postgraduate Medical School, Hammersmith London, prior to joining Professor Alejandro Madrigal at the Anthony Nolan Research Institute. In 2005, Tony was appointed as Professor of Haemato-oncology and Head of Leukaemia Research at NTU. He also continued to head the Immunotherapy Group at the Anthony Nolan Research Institute in London. His legacy exists in the research he undertook in the field of Cancer Immunotherapy and Transplantation Immunology and he was recently involved in the development of the Anthony Nolan Cord Blood Programme, which was developed as a result of his enthusiasm and energy. From the outset, I admired his research ability and determination and consider it to be a distinct privilege as well as pleasure to have known Tony as a colleague and close friend. He is sorely missed by all who knew him and we wish to dedicate this series of papers to his memory. We will not forget Tonys contribution to our research endeavours.